BridgeMD
New treatment option for Stroke
Official title Effects of Combined Neuromuscular Electrical Stimulation Robot and Trans-Spinal Electrical Stimulation in Poststroke Rehabilitation
ClinicalTrials.gov ID: NCT07112911
What this study is testing
- What it's testing
- The purpose of this study is to investigate the clinical efficacy and neurological progress of combined training using trans-spinal electrical stimulation (tsES) and neuromuscular electrical stimulation (NMES)-driven robotics on upper limb rehabilitation after stroke
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 70
You may be able to join if
- people in the chronic stage (start from 6 months after the onset of stroke) with a pure unilateral motor paresis after a stroke (ischemic or...
- Sufficient cognition to follow simple instructions as well as understand the content and purpose of the experiment (Mini-Mental State Examination...
- Be able to sit up for 60 minutes (with or without assistance);
- Muscle strength graded from 1 to 3 in biceps brachii, triceps brachii, extensor carpi radialis, flexor carpi radialis, and abductor pollicis brevis...
- The voluntary electromyographic signals of the wrist extensor and wrist flexor muscle groups can be detected.
You likely can't join if
- Patients with secondary stroke;
- Severe dysphasia (either expressive or comprehensive) with inadequate communication;
- Any additional medical or psychological condition affecting their ability to comply with the study protocol;
- History of other neurological disease, psychiatric disorder, including alcoholism and substance abuse;
- currently pregnant;
- epilepsy;
See the full eligibility criteria
- people in the chronic stage (start from 6 months after the onset of stroke) with a pure unilateral motor paresis after a stroke (ischemic or hemorrhagic);
- Sufficient cognition to follow simple instructions as well as understand the content and purpose of the experiment (Mini-Mental State Examination (MMSE) score\>23);
- Be able to sit up for 60 minutes (with or without assistance);
- Muscle strength graded from 1 to 3 in biceps brachii, triceps brachii, extensor carpi radialis, flexor carpi radialis, and abductor pollicis brevis in the affected side.
- The voluntary electromyographic signals of the wrist extensor and wrist flexor muscle groups can be detected.
- Patients with secondary stroke;
- Severe dysphasia (either expressive or comprehensive) with inadequate communication;
- Any additional medical or psychological condition affecting their ability to comply with the study protocol;
- History of other neurological disease, psychiatric disorder, including alcoholism and substance abuse;
- currently pregnant;
- epilepsy;
- pacemaker implantation or deep brain stimulation;
- involved in drug studies, other clinical trials, or concurrent medication/occupational/physical treatments on the upper limb;
- skin disease at the area of the electrodes;
- High hypertension and cannot maintain normal blood pressure despite daily intake of antihypertensive medication.
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.